ALIM : Summary for Alimera Sciences, Inc. - Yahoo Finance

U.S. Markets closed

Alimera Sciences, Inc. (ALIM)


NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
1.49+0.05 (+3.47%)
At close: 4:00PM EDT
People also watch
PSDVACRXANTHAEGRAPRI
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close1.44
Open1.45
Bid1.45 x 5000
Ask1.96 x 1800
Day's Range1.41 - 1.50
52 Week Range1.01 - 5.15
Volume498,292
Avg. Volume637,854
Market Cap96.65M
Beta2.81
PE Ratio (TTM)-2.37
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Alimera Sciences, Inc. :ALIM-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
    Capital Cube5 days ago

    Alimera Sciences, Inc. :ALIM-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017

    Categories: Yahoo Finance Get free summary analysis Alimera Sciences, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Alimera Sciences, Inc. – Ophthotech Corp., pSivida Corp., Regeneron Pharmaceuticals, Inc., Insmed Incorporated and Aerie Pharmaceuticals, Inc. (OPHT-US, PSDV-US, REGN-US, INSM-US and AERI-US) that have also reported for ... Read more (Read more...)

  • Alimera Sciences, Inc. :ALIM-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017
    Capital Cube11 days ago

    Alimera Sciences, Inc. :ALIM-US: Earnings Analysis: 2016 By the Numbers : March 14, 2017

    Categories: Yahoo Finance Get free summary analysis Alimera Sciences, Inc. reports financial results for the year ended December 31, 2016. We analyze the earnings along side the following peers of Alimera Sciences, Inc. – Ophthotech Corp., pSivida Corp., Regeneron Pharmaceuticals, Inc., Insmed Incorporated and Aerie Pharmaceuticals, Inc. (OPHT-US, PSDV-US, REGN-US, INSM-US and AERI-US) that have also reported for ... Read more (Read more...)

  • Alimera Sciences, Inc. (ALIM) Looks Good: Stock Up 12.8%
    Zacks11 days ago

    Alimera Sciences, Inc. (ALIM) Looks Good: Stock Up 12.8%

    Alimera Sciences, Inc. (ALIM) shares rise almost 13% in the last trading session.